A PHASE 2 DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-RANGING STUDY EVALUATING THE EFFICACY, SAFETY AND TOLERABILITY OF GS 4997 IN SUBJECTS WITH DIABETIC KIDNEY DISEASE
Principal Investigator(s)
Hura,Claudia E.
Funded by
GILEAD SCIENCE
Research Start Date
Status
Inactive